Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000353569-22-000030
Filing Date
2022-03-11
Accepted
2022-03-10 21:32:52
Documents
16
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A qdel-20211231.htm   iXBRL 10-K/A 954041
2 EX-10.40 ex1040hodgesofferletter.htm EX-10.40 11293
3 EX-31.3 ex313.htm EX-31.3 4298
4 EX-31.4 ex314.htm EX-31.4 4389
  Complete submission text file 0000353569-22-000030.txt   1289107

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20211231.xsd EX-101.SCH 2540
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20211231_lab.xml EX-101.LAB 38539
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20211231_pre.xml EX-101.PRE 20535
10 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20211231_htm.xml XML 18612
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-10961 | Film No.: 22730974
SIC: 2835 In Vitro & In Vivo Diagnostic Substances